Upgrade to SI Premium - Free Trial

Neogenomics (NEO) PT Lowered to $18 at Needham

February 18, 2025 4:01 PM
Needham analyst Mike Matson lowered the price target on Neogenomics (NASDAQ: NEO) to $18.00 (from $19.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles